Abstract:Background: Gamma Knife Radiosurgery (GKRS), a specific type of Stereotactic Radiosurgery (SRS), has developed as a significant modality in the treatment of glioblastoma, particularly in conjunction with standard chemotherapy. The goal of this study is to evaluate the efficacy of combining GKRS with surgical resection and chemotherapy in enhancing therapeutic effects for glioblastoma patients aged 55 years and older. Methods: This prospective clinical study, conducted in accordance with the STROBE guidelines, involved 49 glioblastoma patients aged 55 years and older, treated between January 2013 and January 2023. Data were collected prospectively, and strict adherence to the STUPP protocol was maintained. Only patients who conformed to the STUPP protocol were included in the analysis. Due to concerns regarding the cognitive impairment associated with conventional radiotherapy, and at the patients' request, a radiosurgery plan was offered. Radiosurgery was administered for 4–8 weeks following surgical resection. Any patients who had not received previous radiotherapy received open surgical tumor removal, followed by GKRS along with adjuvant chemotherapy. Results: In this prospective clinical study of 49 glioblastoma patients aged 55 years and older, the average lifespan post-histopathological diagnosis was established at 22.3 months (95% CI: 12.0–28.0 months). The median time before disease progression was 14.3 months (95% CI: 13.0–29.7 months). The median duration until the first recurrence after treatment was 15.2 months, with documented cases varying between 4 and 33 months. The Gamma Knife Radiosurgery (GKRS) treatment involved a median marginal recommended dose of 12.5 Gy, targeting an average volume of 5.7 cm3 (range: 1.6–39 cm3). Local recurrence occurred in 21 patients, while distant recurrence was identified in 8 patients. Within the cohort, 34 patients were subjected to further therapeutic approaches, including reoperation, a second GKRS session, the administration of bevacizumab and irinotecan, and PCV chemotherapy. A cognitive function assessment revealed that the patients treated with GKRS experienced significantly less cognitive decline compared to the historical controls, who were treated with conventional radiotherapy. The median MMSE scores declined by 1.9 points over 12 months, and the median MoCA scores declined by 2.9 points. Conclusion: This study demonstrates that Gamma Knife Radiosurgery (GKRS), when integrated with surgical resection and adjuvant chemotherapy, offers a substantial benefit for glioblastoma patients aged 55 years and older. The data reveal that GKRS not only prolongs overall survival and progression-free survival but also significantly reduces cognitive decline compared to conventional radiotherapy. These findings underscore the efficacy and safety of GKRS, advocating for its incorporation into standard treatment protocols for older glioblastoma patients. The potential of GKRS to improve patient outcomes while preserving cognitive function is compelling and warrants further research to optimize and confirm its role in glioblastoma management.

Follow-up study of Gamma knife radiosurgery in treatment of Parkinson's disease

Gamma Knife Radiosurgery for the Treatment of Cavernous Sinus Hemangiomas

Long Term Follow-Up Studies for Postradiosurgical Vestibular Schwannomas

Survival Grading System of Brain Metastases Treated by Gamma Knife Radiosurgery: A Follow-Up Study of 206 Patients

Complications of gamma knife surgery for Parkinson disease

Investigation of Gamma Knife Treatment Effect on Epileptic Foci in Patients with Intractable Epilepsy Localized by PET/CT

GammaKnifeTreatmentfor89CaseswithAcousticNeuromas

Radiosurgical Treatment of Trigeminal Neuralgia: A Follow-Up Experience over Three Years

Gamma Knife Radiosurgery for Intracranial Benign Meningiomas: Follow-Up Outcome in 130 Patients

Gamma Knife Thalamotomy for a Medically Refractory Tremors: Longitudinal Evaluation of Clinical Effects and MRI Response Patterns

Effect analysis of Gamma knife radiosurgery for cavernous sinus cavernous hemangioma

The clinical analysis of Gamma knife radiosurgery for meningeal hemangiopericytomas

Gamma knife surgery for the treatment of brain metastases

Gamma knife radiosurgery for craniopharyngiomas

Primary versus postoperative gamma knife radiosurgery for intracranial benign meningiomas: a matched cohort retrospective study

A preliminary study on a multi-resolution-level inverse planning algorithm for Gamma Knife radiosurgery

Efficacy and Cognitive Outcomes of Gamma Knife Radiosurgery in Glioblastoma Management for Elderly Patients

The clinical report of stereotactic radiosurgery for post-operational low-grade glial tumors

Long-term results of gamma knife radiosurgery for 100 consecutive cases of craniopharyngioma and a treatment strategy

A Preliminary Study on a Multi-Resolution-level Inverse Planning Approach for Gamma Knife Radiosurgery.

Gamma Knife Treatment for 124 Cases with Primary Trigeminal Neuralgia